CalcifediolCalcifediol - High-quality laboratory reagent available from Gentaur. Catalog: 804-HY-32351-01.804-HY-32351-01804-HY-32351-01Business & Industrial > Science & LaboratoryCalcifediol
Gentaur
EUR12027-02-23

Calcifediol

CAT:
804-HY-32351-01
Size:
1 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Calcifediol - image 1

Calcifediol

  • Description:

    Calcifediol (25-hydroxy Vitamin D3) is an effective VDR ligand and VD supplement. Calcifediol is a prohormone of the vitamin D endocrine system (VDES) and is hydroxylated in the liver to produce the active form, calcitriol. Calcifediol can rapidly increase serum VD levels[1][2][3].
  • Product Name Alternative:

    25-Hydroxy Vitamin D3
  • UNSPSC:

    12352211
  • Hazard Statement:

    H301
  • Target:

    Endogenous Metabolite; VD/VDR
  • Type:

    Natural Products
  • Related Pathways:

    Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
  • Applications:

    Metabolism-sugar/lipid metabolism
  • Field of Research:

    Metabolic Disease
  • Assay Protocol:

    https://www.medchemexpress.com/Calcifediol.html
  • Purity:

    99.94
  • Solubility:

    DMSO : ≥ 100 mg/mL
  • Smiles:

    C=C(CC1)/C(C[C@H]1O)=C\C=C2[C@@]3([H])[C@@](CCC\2)(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC3
  • Molecular Formula:

    C27H44O2
  • Molecular Weight:

    400.64
  • Precautions:

    H301
  • References & Citations:

    [1]Castoldi A, et al. Calcifediol-loaded liposomes for local treatment of pulmonary bacterial infections. Eur J Pharm Biopharm. 2016 Nov 22.|[2]Wei Zheng, et al. Vitamin D-induced vitamin D receptor expression induces tamoxifen sensitivity in MCF-7 stem cells via suppression of Wnt/β-catenin signaling. Biosci Rep. 2018 Dec 7;38 (6) :BSR20180595.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    -20°C, 3 years (Powder)
  • Scientific Category:

    Natural Products
  • Clinical Information:

    Launched
  • Isoform:

    Human Endogenous Metabolite
  • Citation 01:

    Front Pharmacol. 2020 Mar 31;11:200.|Int Immunopharmacol. 2023 Sep:122:110558.|Int J Mol Sci. 2017 Dec 19;18 (12) . pii: E2764.|Int J Mol Sci. 2025 Mar 25;26 (7) :2985.|J Sep Sci. 2025 Apr;48 (4) :e70130.|Nat Chem Biol. 2022 Nov;18 (11) :1196-1203.|Proc Natl Acad Sci U S A. 2022 Apr 12;119 (15) :e2117004119.|Ther Adv Endocrinol Metab. 2020 Oct 20:11:2042018820958295.|Virol Sin. 2024 Aug 19:S1995-820X (24) 00134-2.|Sci Rep. 2022 Feb 22;12 (1) :3014.
  • CAS Number:

    [19356-17-3]